Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2007
11/29/2007WO2007135767A1 Guava leaf extract powder and method for production thereof
11/29/2007WO2007135766A1 Ointment for amelioration or treatment of oral tumor
11/29/2007WO2007135703A2 Patch for the treatment of the cellulite and localized adiposity
11/29/2007US20070276045 Anti-Bacterial Compounds
11/29/2007US20070276040 Peptidyl Arginine Deiminase Type IV Inhibitor
11/29/2007US20070276036 Non-Glycosidic and Non-Peptidic Select Inhibitors, and the Use Thereof
11/29/2007US20070276031 Process for Purifying (-)- 9-Trans-Tetrahydrocannabinol
11/29/2007US20070276024 Methods for Treating Diseases and Conditions with Inverse Agonists and for Screening for Agents Acting as Inverse Agonists
11/29/2007US20070276011 Plasminogen Activator Inhibitor-1 Inhibitor
11/29/2007US20070276001 Biphenyl-pyrazolecarboxamide compounds
11/29/2007US20070275973 Aryl fused azapolycyclic compounds
11/29/2007US20070275968 Substituted Biphenyl Derivative
11/29/2007US20070275949 Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2C Receptor Associated Diseases
11/29/2007US20070275924 Synthetic Lipid Rafts and Methods of Use
11/29/2007US20070275921 Oligomeric Compounds That Facilitate Risc Loading
11/29/2007US20070275920 Method for Chromatographic Separation of a Nucleic Acid Mixture
11/29/2007US20070275912 Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
11/29/2007US20070275910 Phosphoramidate Derivatives
11/29/2007US20070275903 oligopeptide conjugates; cleavable by trouase such as Thimet oligopeptidase; antitumor agents
11/29/2007US20070275872 Peptides with Anti-Obesity Activity and Other Related Uses
11/29/2007US20070275440 Regulation of transcription factor, nf-il6/lap
11/29/2007US20070275091 Compositions And Methods For Improved Mucus Function
11/29/2007US20070275089 Argon-based inhalable gaseous medicinal product for the treatment of neurointoxications
11/29/2007US20070275083 ameliorating chronic renal insufficiency, hypertension, atherosclerosis, and chronic congestive heart failure
11/29/2007US20070275079 Antigen-Containing Microspheres for the Treatment of Allergies
11/29/2007US20070275071 Use of Microparticles for Antigen Delivery
11/29/2007US20070275054 Novel composition and use
11/29/2007US20070275011 Inducible Bacterial Expression System Utilising Sspa Promoter from Salmonella
11/29/2007US20070275003 polynucleotides that code for HPV E6/E7 fusion proteins, having mutagenesis points, used to generate immune responses against HPV and prevent or treat cervical cancer
11/29/2007US20070274954 Cloning B and T lymphocytes
11/29/2007US20070274928 Novel Cyclic Oxygenated Compounds Having Cooling, Fragrance, and Flavor Properties, and Uses Thereof
11/29/2007US20070274911 Production of 2-18F-2-Deoxy-D-Glucose Via Solid-Phase Synthesis
11/29/2007DE10259834B4 Test und Screeningverfahren zur Identifizierung von Inhibitoren von Beta-Sekretasen Test and screening methods for identifying inhibitors of beta secretases
11/29/2007CA2653042A1 Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
11/29/2007CA2652484A1 Heterocyclic type cinnamide derivative
11/29/2007CA2651733A1 Guava leaf extract powder and method for production thereof
11/29/2007CA2651500A1 Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds
11/29/2007CA2651487A1 Methods for treating chemotherapy and radiation therapy side effects
11/29/2007CA2651420A1 Spiro tetracyclic compound
11/28/2007EP1860187A1 Apo-2 receptor
11/28/2007EP1860115A1 Oligonucleotide derivative, probe for detection of gene, and dna chip
11/28/2007EP1860114A1 Nitroguanosine-3 ,5 -cyclic monophosphate and protein kinase g activator
11/28/2007EP1860106A1 Tricyclic thrombin receptor antagonists
11/28/2007EP1859834A1 Anti-inflammatory agent
11/28/2007EP1859812A1 Polycation chargeable polymer and use as carrier of nucleic acid
11/28/2007EP1859804A1 Anticancer agent to be combined with telomelysin
11/28/2007EP1859803A1 Promoter for hard tissue formation
11/28/2007EP1859795A1 Therapeutic agent for ophthalmic disease
11/28/2007EP1859793A1 Novel combinational use of sulfonamide compound
11/28/2007EP1859774A1 Hair cosmetic
11/28/2007EP1553909A4 Quick dissolve compositions and tablets based thereon
11/28/2007EP1542710A4 Methods for preserving organs and tissues
11/28/2007EP1534674A4 Cytotoxic agents containing novel potent taxanes and their therapeutic use
11/28/2007EP1406613B1 Organic nitratederivatives for the treatment of atherosclerosis and vascular diseases
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1328245B1 Dental care compositions
11/28/2007EP1315718B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
11/28/2007EP1261322B1 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
11/28/2007EP0991666B1 Alpha 1-antitrypsin preparation and method for the production thereof
11/28/2007EP0977844B1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
11/28/2007EP0937103B1 Compounds and methods for modulating cell adhesion
11/28/2007CN101080421A Antibody and utilization of the same
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN101077192A Process for producing sugar ginseng
11/28/2007CN101077152A Pearl facial-nourishing bean product and its manufacturing method
11/28/2007CN101077104A Gynostemma pentaphyllum tea
11/28/2007CN101077096A Tea for recuperating sub-health
11/28/2007CN100351255C Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors
11/28/2007CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/28/2007CN100351241C Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof
11/28/2007CN100351236C 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
11/28/2007CN100351235C 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composi
11/28/2007CN100351234C Bis-heterocyclic compounds with antitumour and chemosensitising activity
11/28/2007CN100351233C Fullerene derivative of E-isomer
11/28/2007CN100350981C Radioactive therapeutic Liposomes
11/28/2007CN100350977C Medicinal compositions
11/28/2007CN100350973C Drug composition for curing disease produced from IL-6
11/28/2007CN100350968C Modification of feeding behavior
11/28/2007CN100350945C Process for treating Pengze fritillary bulb and preparing capsules
11/28/2007CN100350896C Raw rhubarb powder injection and its prepn
11/27/2007US7301028 Mitotic kinesin inhibitors
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/27/2007US7301005 Immunomodulatory peptides derived from heat shock proteins and uses thereof
11/27/2007US7300952 NF-κb inhibitors
11/27/2007US7300950 Pyrazole derivatives, their preparation and their use in pharmaceuticals
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007US7300935 Gonadotropin-releasing hormone antagonistic activity, therapy of prostatic cancer, endometriosis, precocious puberty; N-(4-(1-(2,6-difluorobenzyl)-5-(((2-ethoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea
11/27/2007US7300933 Diazabicyclic biaryl derivatives
11/27/2007US7300922 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
11/27/2007US7300919 Pulmonary delivery of active fragments of parathyroid hormone
11/27/2007US7300917 Remedy for chronic disease
11/27/2007US7300765 SC6 for diagnosis of cancers
11/27/2007US7300672 Producing ion vapor using plasma discharge; microdispersions; health products, cosmetics
11/27/2007US7300662 Local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography, lower systemic toxicity
11/27/2007US7300656 Treatment of inflammatory bowel disease with IFN-gamma inhibitors
11/27/2007CA2432196C Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
11/27/2007CA2379695C Compounds for modulating the rage receptor
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
1 ... 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 ... 1564